News
News
- Nicox: 2021 Extraordinary and Ordinary Shareholder Meetings
17:45 - GlobeNewswire - Recruitment and Enrollment Underway at Eight Sites for Innovation Pharma’s Phase 2 Clinical Trial of Brilacidin for COVID-19
17:31 - GlobeNewswire - Claritas (formerly Kalytera Therapeutics, Inc.) Announces Addition of Professor Salvatore Cuzzocrea, Ph.D. to the Company’s Board of Directors
14:30 - GlobeNewswire - Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
14:30 - GlobeNewswire - Timber Pharmaceuticals Announces Presentation at 2021 H.C. Wainwright Global Life Sciences Conference
14:30 - GlobeNewswire - Quantum Leap Healthcare Collaborative Discontinues Testing of Aerpio Pharmaceutical’s Razuprotafib in I-SPY COVID Trial
14:00 - GlobeNewswire - Imara Reports Full Year 2020 Financial Results and Business Highlights
13:00 - GlobeNewswire - Polyphor Announces Financial Results for the Full-Year 2020
07:15 - GlobeNewswire - Dr. Henry Ji to Participate in the H.C. Wainwright Virtual GLOBAL LIFE SCIENCES CONFERENCE 2021 Investor Conference
07:06 - GlobeNewswire - Hyloris’ Partner AFT Pharmaceuticals Signs Licensing Agreement with Aguettant for Maxigesic® IV in Eight European Markets
07:00 - GlobeNewswire
Real-time